Sionna Therapeutics (SION) Research & Development (2024 - 2026)
Sionna Therapeutics (SION) posted Research & Development of $19.0 million for Q1 2026, up 25.02% sequentially from $15.2 million in Q4 2025, and up 38.74% YoY from $13.7 million in Q1 2025.
Sionna Therapeutics (SION) Research & Development (2024 - 2026) Analysis & Trends
Sionna Therapeutics has reported Research & Development for 3 years, with the latest figure at $19.0 million in Q1 2026.
- Quarterly Research & Development rose 38.74% year-over-year to $19.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $65.6 million (up 7.94% YoY) and the FY2025 annual result came in at $60.3 million, up 5.19% from the prior year.
- Research & Development improved to $19.0 million in Q1 2026 per SION's latest filing, from $15.2 million in the prior quarter.
- Over five years, Research & Development peaked at $24.6 million in Q3 2024 and troughed at $8.2 million in Q2 2024.
- A 3-year average of $15.2 million and a median of $15.2 million in 2025 frame the typical range for Research & Development.
- The widest YoY moves for Research & Development: up 86.85% in 2025, down 34.73% in 2025.
- Over 3 years, Research & Development stood at $14.3 million in 2024, then climbed by 6.42% to $15.2 million in 2025, then increased by 25.02% to $19.0 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $19.0 million, $15.2 million, and $16.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 993.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.63 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.37 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 394.92 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 612.28 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 1,146.05 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 97.90 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 413.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 210.03 Mn |
| 10 | Sionna Therapeutics | 291.76 Mn | 291.76 Mn | - | 21.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.86 Mn |
| Mar 31, 2026 | 18.96 Mn |
| Dec 31, 2025 | 15.17 Mn |
| Sep 30, 2025 | 16.04 Mn |
| Jun 30, 2025 | 15.38 Mn |
| Mar 31, 2025 | 13.67 Mn |
| Dec 31, 2024 | 14.25 Mn |
| Sep 30, 2024 | 24.58 Mn |
| Jun 30, 2024 | 8.23 Mn |
| Mar 31, 2024 | 10.22 Mn |